Literature DB >> 29447088

Increasing incidence and survival of head and neck cancers in Denmark: a nation-wide study from 1980 to 2014.

Kathrine Kronberg Jakobsen1, Christian Grønhøj1, David Hebbelstrup Jensen1, Kirstine Kim Schmidt Karnov1, Tina Klitmøller Agander2, Lena Specht3, Christian von Buchwald1.   

Abstract

BACKGROUND: The purpose of the study was to determine trends in age-adjusted incidence rates (AAIR) and survival probability in head and neck cancers (HNCs) in the Danish population from 1980 to 2014.
MATERIAL AND METHODS: All patients registered with HNC in the nationwide Danish Cancer Registry from 1980 to 2014 were included. We evaluated the AAIR per 100,000 and the average annual percent change (AAPC). The relative survival probability at 5 years was calculated in relation to gender, anatomical location and histology, and we constructed age-period-cohort models of incidence.
RESULTS: About 34,606 patients were included (64.7% men). The AAIR increased from 9.1 per 100,000 in 1980 to 17.4 per 100,000 in 2014 with an AAPC of 2.1%. The greatest incidence increase was observed in oropharyngeal cancer (AAPC: 5.4%) followed by hypopharyngeal cancer (AAPC: 4.2%). Adenocarcinomas had the highest AAPC (5.0%) followed by squamous cell carcinomas (AAPC: 2.0%). The AAPC was significantly higher in women (2.4%) compared with men (1.6%). For all HNC patients, the relative survival at 5 years rose significantly from 49.0% in 1980-1984 to 62.4% in 2010-2014. Women had a significantly higher survival than men with a relative survival of 61.7% compared to 50.0% in men. Laryngeal cancer had the best survival probability of cancers in the upper aerodigestive tract with hypopharyngeal cancer having the poorest survival.
CONCLUSION: This nation-wide study showed a significant rise in incidence of HNC for men and women along with a significant increase in relative survival. Oropharyngeal cancer had the highest increase in incidence followed by hypopharyngeal cancer which showed the poorest survival of HNCs.

Entities:  

Mesh:

Year:  2018        PMID: 29447088     DOI: 10.1080/0284186X.2018.1438657

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  12 in total

1.  To eat is to practice-managing eating problems after head and neck cancer.

Authors:  Marianne Boll Kristensen; Tina Broby Mikkelsen; Anne Marie Beck; Ann-Dorthe Zwisler; Irene Wessel; Karin B Dieperink
Journal:  J Cancer Surviv       Date:  2019-08-24       Impact factor: 4.442

2.  Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with 18F-FDG PET/CT: A Single-Center Prospective Study.

Authors:  Louise M Risør; Malene M Clausen; Zaza Ujmajuridze; Mohammed Farhadi; Kim F Andersen; Annika Loft; Jeppe Friborg; Andreas Kjaer
Journal:  J Nucl Med       Date:  2021-12-02       Impact factor: 11.082

3.  Effects of a Multidisciplinary Residential Nutritional Rehabilitation Program in Head and Neck Cancer Survivors-Results from the NUTRI-HAB Randomized Controlled Trial.

Authors:  Marianne Boll Kristensen; Irene Wessel; Anne Marie Beck; Karin B Dieperink; Tina Broby Mikkelsen; Jens-Jakob Kjer Møller; Ann-Dorthe Zwisler
Journal:  Nutrients       Date:  2020-07-17       Impact factor: 5.717

4.  Early mortality after diagnosis of cancer of the head and neck - A population-based nationwide study.

Authors:  Charbél Talani; Antti Mäkitie; Martin Beran; Erik Holmberg; Göran Laurell; Lovisa Farnebo
Journal:  PLoS One       Date:  2019-10-02       Impact factor: 3.240

5.  The Copenhagen Oral Cavity Squamous Cell Carcinoma database: protocol and report on establishing a comprehensive oral cavity cancer database.

Authors:  Jakob Schmidt Jensen; Kathrine Kronberg Jakobsen; Christian Mirian; Julie Thor Christensen; Katrine Schneider; Arvin Nahavandipour; Vibe Lindeblad Wingstrand; Irene Wessel; Jesper Filtenborg Tvedskov; Thomas Frisch; Anders Christensen; Lena Specht; Elo Andersen; Giedrius Lelkaitis; Christian Grønhøj; Christian von Buchwald
Journal:  Clin Epidemiol       Date:  2019-08-19       Impact factor: 4.790

6.  Successful Use of Nivolumab in a Patient with Head and Neck Cancer After Allogeneic Bone Marrow Transplantation.

Authors:  Xiaopei Dong; Ning Lu; Zhongsheng Tong; Yehui Shi
Journal:  Onco Targets Ther       Date:  2021-02-10       Impact factor: 4.147

7.  Incidence and Survival for Head and Neck Cancers in Estonia, 1996-2016: A Population-Based Study.

Authors:  Sandra Kase; Aleksei Baburin; Maire Kuddu; Kaire Innos
Journal:  Clin Epidemiol       Date:  2021-02-24       Impact factor: 4.790

8.  Incidence and survival of head and neck cancer in the Faroe Islands.

Authors:  Sunnvá Hanusardóttir Olsen; Jeppe Friborg; Bjarki Ellefsen; Kathrine Kronberg Jakobsen; Kasper Aanæs
Journal:  Int J Circumpolar Health       Date:  2021-12       Impact factor: 1.228

9.  Survival trends of patients with oral and oropharyngeal cancer treated at a cancer center in São Paulo, Brazil.

Authors:  Luiz Paulo Kowalski; Max Moura de Oliveira; Rossana Veronica Mendoza Lopez; Diego Rodrigues Mendonça E Silva; Mauro Kazuo Ikeda; Maria Paula Curado
Journal:  Clinics (Sao Paulo)       Date:  2020-04-06       Impact factor: 2.365

10.  Rationale and design of a randomised controlled trial investigating the effect of multidisciplinary nutritional rehabilitation for patients treated for head and neck cancer (the NUTRI-HAB trial).

Authors:  Marianne Boll Kristensen; Irene Wessel; Anne Marie Beck; Karin B Dieperink; Tina Broby Mikkelsen; Jens-Jakob Kjer Møller; Ann-Dorthe Zwisler
Journal:  Nutr J       Date:  2020-03-17       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.